Crohn’s & Colitis Foundation Hosts Educational Program on Emerging Advances in Crohn’s Disease Treatments

Share Article

On Wednesday, October 6 at 1 pm EST the Crohn’s & Colitis Foundation of America will host an educational program on emerging advances in Crohn’s disease treatments for patients, family members and caregivers living with Crohn’s disease, a chronic and often debilitating digestive disease affecting over 700,000 Americans. This interactive webcast/ teleconference, Progress in CD: An Update On the Advances In Crohn’s Disease, which is supported by an educational grant from Centocor Ortho Biotech Inc, is now open for registration at http://www.ccfa.org/webcasts/CrohnsUpdate.

News Image
I highly encourage all Crohn’s patients and their caregivers nationwide to take advantage of this opportunity and tune in to the event.

On Wednesday, October 6 at 1 pm EST the Crohn’s & Colitis Foundation of America will host an educational program on emerging advances in Crohn’s disease treatments for patients, family members and caregivers living with Crohn’s disease, a chronic and often debilitating digestive disease affecting over 700,000 Americans. This interactive webcast/ teleconference, Progress in CD: An Update On the Advances In Crohn’s Disease, which is supported by an educational grant from Centocor Ortho Biotech Inc, is now open for registration at http://www.ccfa.org/webcasts/CrohnsUpdate.

The program will be led by Dr. Jonathan Braun, M.D., Ph.D., Professor of Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology, at the David Geffen School of Medicine at UCLA. He will discuss the emerging advances and progress in treating and understanding Crohn’s disease and answer audience questions during an interactive question-and-answer session.

“New discoveries and therapies for Crohn’s disease are emerging and through the Crohn’s disease update event on October 6, patients nationwide can tune in and hear more about recent discoveries and the latest treatments,” explains Dr. Braun. “I highly encourage all Crohn’s patients and their caregivers nationwide to take advantage of this opportunity and tune in to the event.”

This educational event is available at no cost to participants. It will answer important questions about Crohn’s disease, including:

  •     What are the current and emerging therapies for Crohn’s disease?
  •     How is research targeting and utilizing genetics?
  •     What is new in pediatric research?

About Crohn's Disease and Ulcerative Colitis

Crohn's disease and ulcerative colitis are painful, medically incurable illnesses that attack the digestive system. Crohn's disease may attack anywhere, while ulcerative colitis inflames only the large intestine (colon). Symptoms may include abdominal pain, bleeding, fever and weight loss. Many patients require hospitalization and surgery. These illnesses can cause severe complications, including colon cancer in patients with long-term disease. Some 1.4 million American adults and children suffer from Crohn's disease or ulcerative colitis, with as many as 150,000 under the age of 18. Most people develop the diseases between the ages of 15 and 35.

About the Crohn’s & Colitis Foundation of America

The Crohn's & Colitis Foundation of America's mission is to cure Crohn's disease and ulcerative colitis, and to improve the quality of life of children and adults affected by these diseases. The Foundation ranks third among leading health non-profits in the percentage of expense devoted to research toward a cure, with more than 79 cents of every dollar the Foundation spends goes to mission-critical programs. The Foundation consistently meets the standards of organizations that monitor charities, including the Better Business Bureau's Wise Giving Alliance (give.org) and the American Institute of Philanthropy (charitywatch.org). For more information, contact the Foundation at 800-932-2423 or visit http://www.ccfa.org. Join CCFA on Facebook at http://apps.facebook.com/supportccfa/ and follow CCFA on Twitter at http://www.twitter.com/ccfa.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ariella Levine
Visit website